GMB-475 is primarily utilized in the field of medical research, particularly in the study of neurodegenerative diseases. It has shown promise in modulating specific pathways associated with neuronal protection and regeneration, making it a potential candidate for therapeutic development. Researchers are exploring its efficacy in conditions such as Alzheimer's and Parkinson's disease, where it may help mitigate neuronal damage and improve cognitive function. Additionally, GMB-475 is being investigated for its role in enhancing synaptic plasticity, which is crucial for learning and memory processes. Its application extends to preclinical studies, where it is used to better understand the molecular mechanisms underlying neurodegeneration and to identify potential drug targets.